Kopnin P - Search Results

1

Inhibition of FGF2-Mediated Signaling in GIST-Promising Approach for Overcoming Resistance to Imatinib.

Boichuk S, Galembikova A, Mikheeva E, Bikinieva F, Aukhadieva A, Dunaev P, Khalikov D, Petrov S, Kurtasanov R, Valeeva E, Kireev I, Dugina V, Lushnikova A, Novikova M, Kopnin P. Boichuk S, et al. Among authors: kopnin p. Cancers (Basel). 2020 Jun 24;12(6):1674. doi: 10.3390/cancers12061674. Cancers (Basel). 2020. PMID: 32599808 Free PMC article. Review.

2

Tumor promotion by γ and suppression by β non-muscle actin isoforms.

Dugina V, Khromova N, Rybko V, Blizniukov O, Shagieva G, Chaponnier C, Kopnin B, Kopnin P. Dugina V, et al. Among authors: kopnin b, kopnin p. Oncotarget. 2015 Jun 10;6(16):14556-71. doi: 10.18632/oncotarget.3989. Oncotarget. 2015. PMID: 26008973 Free PMC article.

3

E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth.

Farmakovskaya M, Khromova N, Rybko V, Dugina V, Kopnin B, Kopnin P. Farmakovskaya M, et al. Among authors: kopnin b, kopnin p. Cell Cycle. 2016;15(8):1084-92. doi: 10.1080/15384101.2016.1156268. Cell Cycle. 2016. PMID: 26940223 Free PMC article.

4

Interaction of microtubules with the actin cytoskeleton via cross-talk of EB1-containing +TIPs and γ-actin in epithelial cells.

Dugina V, Alieva I, Khromova N, Kireev I, Gunning PW, Kopnin P. Dugina V, et al. Among authors: kopnin p. Oncotarget. 2016 Nov 8;7(45):72699-72715. doi: 10.18632/oncotarget.12236. Oncotarget. 2016. PMID: 27683037 Free PMC article.

5

[A change in the expression of membrane-associated proteins and cytoplasmic actin isoforms in the progression of human colon tumors].

Novikova MV, Rybko VA, Kochatkov AV, Khromova NV, Bogomazova SY, Dugina VB, Lyadov VK, Kopnin PB. Novikova MV, et al. Among authors: kopnin pb. Arkh Patol. 2017;79(2):15-21. doi: 10.17116/patol201779215-21. Arkh Patol. 2017. PMID: 28418353 Russian.

6

Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.

Novikova MV, Khromova NV, Kopnin PB. Novikova MV, et al. Among authors: kopnin pb. Biochemistry (Mosc). 2017 Aug;82(8):861-873. doi: 10.1134/S0006297917080016. Biochemistry (Mosc). 2017. PMID: 28941454 Review.

7

Mitochondria-targeted antioxidant SkQ1 suppresses fibrosarcoma and rhabdomyosarcoma tumour cell growth.

Titova E, Shagieva G, Ivanova O, Domnina L, Domninskaya M, Strelkova O, Khromova N, Kopnin P, Chernyak B, Skulachev V, Dugina V. Titova E, et al. Among authors: kopnin p. Cell Cycle. 2018;17(14):1797-1811. doi: 10.1080/15384101.2018.1496748. Epub 2018 Jul 31. Cell Cycle. 2018. PMID: 29995559 Free PMC article.

8

Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo.

Boichuk S, Galembikova A, Dunaev P, Micheeva E, Valeeva E, Novikova M, Khromova N, Kopnin P. Boichuk S, et al. Among authors: kopnin p. Molecules. 2018 Oct 15;23(10):2643. doi: 10.3390/molecules23102643. Molecules. 2018. PMID: 30326595 Free PMC article.

9

Divergent impact of actin isoforms on cell cycle regulation.

Dugina V, Shagieva G, Khromova N, Kopnin P. Dugina V, et al. Among authors: kopnin p. Cell Cycle. 2018;17(23):2610-2621. doi: 10.1080/15384101.2018.1553337. Epub 2018 Dec 5. Cell Cycle. 2018. PMID: 30516087 Free PMC article.

10

Ethyl-2-amino-pyrrole-3-carboxylates are active against imatinib-resistant gastrointestinal stromal tumors in vitro and in vivo.

Boichuk S, Galembikova A, Dunaev P, Micheeva E, Novikova M, Khromova N, Kopnin P. Boichuk S, et al. Among authors: kopnin p. Anticancer Drugs. 2019 Jun;30(5):475-484. doi: 10.1097/CAD.0000000000000753. Anticancer Drugs. 2019. PMID: 30986804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page